Home Ventilators (noninvasive and invasive)
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.MP.184 alerts
Get alerted when Policy CP.MP.184 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity criteria and coverage guidance for initial and continued use of home noninvasive and invasive ventilators for non‑Medicare health plans affiliated with Centene Corporation, affecting providers caring for eligible members/enrollees.
No material clinical or coverage changes in this revision.
Coverage Criteria for Home Ventilators
Initial use — Restrictive thoracic disorders / neuromuscular disease
Covered when ALL of the following are met for the initial request (first three months) for noninvasive home ventilator use:
Initial period specified as first three months.
Initial use — Chronic respiratory failure due to COPD
Covered when ALL of the following are met for the initial request (first three months):
Initial period specified as first three months; I.B rewording and restructuring per revision log.
Initial use — Obesity hypoventilation syndrome (OHS)
Covered when ALL of the following are met for the initial request (first three months):
Initial period specified as first three months.
Continued use (post-initial certification)
Covered when ALL of the following are met:
Three‑month specification removed from continued‑use criteria.
Invasive ventilator use (initial and ongoing)
Covered when used for long-term/chronic conditions affecting ability to maintain adequate respiratory status, examples include:
Used for long‑term/chronic conditions requiring invasive support.
Second or back-up ventilator
Covered when ANY of the following are met:
Second/back‑up ventilators considered medically necessary for these indications.
The policy specifies that noninvasive home ventilators are medically necessary for initial use (first three months) in defined clinical groups when all listed criteria are met. For restrictive thoracic disorders or neuromuscular disease, coverage requires: documentation of a neuromuscular disease or severe thoracic cage abnormality and one of the following while the member is stable — PaCO2 ≥ 45 mm Hg measured awake on room air or prescribed oxygen, sleep oximetry showing ≤ 88% O2 saturation for ≥ 5 minutes on prescribed O2, or (if neuromuscular disease) maximal inspiratory pressure < 60 cm H2O or FVC < 50% predicted; documentation that the member could not be appropriately treated with a respiratory assist device (RAD) and that the NIV will not be used to provide RAD or CPAP (it will be used for average volume‑assured pressure support); and that COPD does not contribute significantly to the pulmonary limitation.
For chronic respiratory failure due to COPD (initial three months), coverage requires all of the following: PaCO2 ≥ 52 mm Hg on arterial blood gas obtained while awake and breathing prescribed FiO2; documentation that sleep apnea is not the predominant cause of hypercapnia; evidence of at least one of the ventilatory/oxygen needs (e.g., FiO2 ≥ 36% or ≥ 4 L nasal oxygen, ventilatory support > 8 hours/24 hours, or requirement for a home mechanical ventilator with alarms and internal battery because of inability to breathe independently for more than a few hours); and documentation that RAD is not appropriate and the NIV will not be used to provide RAD/CPAP but rather for average volume‑assured pressure support.
For obesity hypoventilation syndrome (OHS) (initial three months), coverage requires BMI ≥ 30; an initial baseline arterial PaCO2 ≥ 45 mm Hg while awake and breathing prescribed FiO2; documentation of sleep‑disordered hypoventilation by polysomnography with other conditions not considered the primary cause of hypoventilation; and documentation that RAD is not appropriate and the NIV will not be used to provide RAD or CPAP but will be used for average volume‑assured pressure support.
The policy also defines criteria for continued (post‑initial) use: the device must be used an average of ≥ 4 hours per 24‑hour period, and documentation must demonstrate ongoing clinical benefit and that the NIV is not being used to provide RAD or CPAP (it continues to be used for average volume‑assured pressure support).
The policy addresses invasive ventilator use (initial and ongoing) as medically necessary when used for long‑term or chronic conditions that impair the ability to maintain adequate respiratory status or protect the airway (examples include neuromuscular disease, thoracic restrictive disease, or chronic respiratory failure following COPD).
A second or back‑up ventilator may be covered when any of the following apply: it serves a different medical purpose (e.g., negative‑pressure device plus positive‑pressure device), the member requires separate ventilators for different settings (for example, wheelchair‑mounted ventilator for daytime mobility and a separate bed ventilator), or the member lives in a remote area with limited emergency access where a back‑up device is medically necessary.
Coverage and payment are governed by the Health Plan's medical necessity guidelines and the member's coverage documents. Where state Medicaid provisions conflict with this clinical policy, state Medicaid coverage provisions take precedence; for Medicare members, applicable National Coverage Determinations, Local Coverage Determinations, and Medicare Coverage Articles should be reviewed and applied as appropriate.
Providers are required to submit documentation consistent with the Health Plan's administrative policies and to exercise professional medical judgment. Prior authorization requirements and applicability of the policy must align with the member's coverage terms and any applicable state or federal rules.
The policy was revised to remove prior criteria that referenced BiPAP failure and BiPAP treatment‑failure indications. In place of those removal items, the policy now requires explicit documentation that the member could not be appropriately treated with a respiratory assist device (RAD) and that the noninvasive ventilator will not be used to provide RAD or CPAP therapy (the ventilator must be used for average volume‑assured pressure support).
These changes include wording updates (e.g., PaCO2 thresholds clarified, BMI threshold set to ≥ 30 for OHS, and the initial certification period specified as the first three months) and removal of BiPAP failure criteria so requests lacking the new required documentation (diagnosis‑specific physiologic measurements, RAD appropriateness statement, and intent not to use NIV for RAD/CPAP) may be denied.
Coding and Clinical Thresholds
| E0465 | Home ventilator, any type, used with invasive interface (e.g., tracheostomy tube). |
| E0466 | Home ventilator, any type, used with noninvasive interface (e.g., mask, chest shell). |
| E0467 | Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation; includes all accessories, components and supplies for all functions. |
| E0468 | Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation; includes all accessories, components and supplies for all functions. |
Provider Actions, Documentation, and Authorization
Document medical necessity and bill with E0465–E0468
Initial and continued use of home ventilators for covered indications requires submission of clinical documentation that meets the policy clinical criteria and use of the referenced HCPCS codes for billing: E0465, E0466, E0467, and E0468.
Obtain prior authorization per Health Plan and member coverage
Prior authorization, coverage determination, and payment are governed by the Health Plan's medical necessity guidelines and the member's coverage documents; prior authorization requirements must align with applicable state Medicaid or Medicare rules where they apply.
- Coverage decisions are subject to terms, conditions, exclusions and limitations of the member's coverage documents.
- For Medicaid members, state Medicaid provisions take precedence when they conflict with this policy; for Medicare members, review applicable NCDs/LCDs.
Document RAD/CPAP inappropriateness and intended ventilator use
For initial authorization, document that the member could not be appropriately treated with a respiratory assist device (RAD) and verify the noninvasive ventilator will not be used to provide RAD or CPAP therapy (it must be used to provide average volume‑assured pressure support).
- Include explicit statement that RAD/CPAP is not appropriate for this member.
- Confirm intended ventilator use is for average volume assured pressure support, not RAD/CPAP.
Provider-action highlight (placeholder)
Placeholder for provider-action highlight.
Submit required diagnostic and physiologic documentation
Provide medical record documentation of the member's diagnosis (examples: neuromuscular disease, severe thoracic cage abnormality, COPD, or obesity hypoventilation syndrome), required physiologic tests (e.g., arterial blood gas PaCO2, sleep oximetry or polysomnography where specified), and evidence that RAD/CPAP are not appropriate; for continued use include device use averaging ≥ 4 hours per 24‑hour period and documentation of ongoing benefit.
- Diagnostic documentation: neuromuscular disease, thoracic cage abnormality, COPD, or OHS.
- Physiologic tests: arterial blood gas PaCO2 (thresholds specified in policy), sleep oximetry or polysomnography as applicable.
- For continued use: average device use ≥ 4 hours/24 hours and evidence of ongoing benefit.
- Statement that RAD/CPAP is not appropriate and ventilator will be used for average volume‑assured pressure support.
Adhere to Health Plan administrative policies and exercise clinical judgment
Follow the Health Plan's administrative policies and submit documentation consistent with the member's coverage terms; providers are expected to exercise professional medical judgment when treating members.
- Ensure submitted records and requests align with the member's evidence of coverage and Health Plan procedures.
- Provider clinical judgment remains responsibility of treating clinician.
Risk of denial if physiologic measures or RAD documentation are missing
Requests that lack documentation of the required diagnosis‑specific physiologic measurements or lack evidence that RAD/CPAP is inappropriate may be denied. Examples include missing arterial PaCO2 values, absent sleep oximetry or polysomnography when specified, or no statement that RAD is unsuitable.
- PaCO2 thresholds required by indication (e.g., ≥ 45 mm Hg or ≥ 52 mm Hg) must be documented.
- Sleep oximetry or polysomnography results must be provided when specified by the criteria.
- Documentation must state RAD is not appropriate and ventilator will not be used for RAD/CPAP.
Coverage decisions follow member coverage and state/Medicare rules — denial risk if inconsistent
Coverage decisions are subject to the terms, conditions, exclusions and limitations of the member's coverage documents; when state Medicaid provisions conflict with this policy, the state Medicaid manual takes precedence.
- Verify member-specific coverage documents and state Medicaid rules before submitting requests.
- Discrepancies between this clinical policy and coverage documents may affect authorization and payment.
Background
Respiratory failure is the inability to adequately oxygenate or eliminate carbon dioxide and may be acute or chronic. Noninvasive ventilation (NIV) delivers positive pressure to the lungs via masks or similar interfaces and is used in home and critical‑care settings to support ventilation, reduce symptoms, improve quality of life, decrease readmissions, and reduce mortality. Invasive ventilation is delivered via an invasive airway (for example, a tracheostomy) and is indicated when a patient cannot maintain adequate ventilation or airway protection.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.